Metabolic changes in human CD36 deficiency displayed by glucose loading

Thrombosis and Haemostasis

Volumn 86, Issue 4, 2001, Pages 995-999

  Yanai, H ^a   Chiba, H ^a   Fujiwara, H ^a   Morimoto, M ^a   Takahashi, Y ^a   Hui, S P ^a   Fuda, H ^a   Akita, H ^a   Kurosawa, T ^a   Kobayashi, K ^a   Matsuno, K ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Fatty acids; Insulin; Triglyceride

Indexed keywords

CARRIER PROTEIN; CD36 ANTIGEN; FATTY ACID; GLUCOSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME KINETICS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; MALE; METABOLIC DISORDER; MUSCLE FUNCTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034762084     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616523     Document Type: Article

References (24)

1. Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins
2. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membrane
3. Expression cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: Homology with human CD36
4. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
5. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
6. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin
7. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
8. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency)
9. Putative membrane fatty acid translocase and cytoplasmic acid-binding protein are co-expressed in rat heart and skeletal muscles
10. Co-expression in rat heart and skeletal muscle of four genes coding for proteins implicated in long-chain fatty acid uptake
11. Molecular basis of CD36 deficiency
12. Identification of molecular defects in a subject with type I CD36 deficiency
13. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency
14. Platelet glycoprotein IV (CD36) deficiency is associated with the presence (type II) or the absence (type I) of glycoprotein IV on monocytes
15. Phenotype-genotype correlation in CD36 deficiency type I and II
16. Effects of insulin on human adipose tissue metabolism in vivo
17. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
18. Expression of the CD36 homolog (FAT) in fibroblast cells: Effects on fatty acid transport
19. Insulin-stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor
20. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
21. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance
22. Type I CD36 deficiency in humans is not associated with insulin resistance syndrome
23. Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion
24. Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol